These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22357572)

  • 21. A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression.
    Toniolo RA; Silva M; Fernandes FBF; Amaral JAMS; Dias RDS; Lafer B
    J Neural Transm (Vienna); 2018 Feb; 125(2):247-257. PubMed ID: 29177955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
    Sachs GS; Ice KS; Chappell PB; Schwartz JH; Gurtovaya O; Vanderburg DG; Kasuba B
    J Clin Psychiatry; 2011 Oct; 72(10):1413-22. PubMed ID: 21672493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levetiracetam in the management of bipolar depression: a randomized, double-blind, placebo-controlled trial.
    Saricicek A; Maloney K; Muralidharan A; Ruf B; Blumberg HP; Sanacora G; Lorberg B; Pittman B; Bhagwagar Z
    J Clin Psychiatry; 2011 Jun; 72(6):744-50. PubMed ID: 21034692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minocycline as adjunctive treatment for major depressive disorder: Pooled data from two randomized controlled trials.
    Zazula R; Husain MI; Mohebbi M; Walker AJ; Chaudhry IB; Khoso AB; Ashton MM; Agustini B; Husain N; Deakin J; Young AH; Berk M; Kanchanatawan B; Ng CH; Maes M; Berk L; Singh AB; Malhi GS; Dean OM
    Aust N Z J Psychiatry; 2021 Aug; 55(8):784-798. PubMed ID: 33092404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, double-blind, placebo-controlled study of flexible doses of levomilnacipran ER (40-120 mg/day) in patients with major depressive disorder.
    Gommoll CP; Greenberg WM; Chen C
    J Drug Assess; 2014; 3(1):10-9. PubMed ID: 27536449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study protocol for a randomised placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment resistant bipolar depression (the PAX-BD study).
    Azim L; Hindmarch P; Browne G; Chadwick T; Clare E; Courtney P; Dixon L; Duffelen N; Fouweather T; Geddes JR; Goudie N; Harvey S; Helter T; Holstein EM; Martin G; Mawson P; McCaffery J; Morriss R; Simon J; Smith D; Stokes PRA; Walker J; Weetman C; Wolstenhulme F; Young AH; Watson S; McAllister-Williams RH
    BMC Psychiatry; 2021 Jul; 21(1):334. PubMed ID: 34225686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomised, double-blind, active placebo-controlled, parallel groups, dose-response study of scopolamine hydrobromide (4-6 μg/kg) in patients with major depressive disorder.
    Chen JCC; Sumner RL; Krishnamurthy Naga V; Hoeh N; Ayeni HA; Singh V; Sundram F; Campbell D; Muthukumaraswamy S
    Trials; 2020 Feb; 21(1):157. PubMed ID: 32041658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjunctive simvastatin for treatment-resistant depression: study protocol of a 12-week randomised controlled trial.
    Husain MI; Chaudhry IB; Khoso AB; Husain MO; Rahman RR; Hamirani MM; Hodsoll J; Carvalho AF; Husain N; Young AH
    BJPsych Open; 2019 Jan; 5(1):e13. PubMed ID: 30762508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trial.
    Lisiecka DM; Suckling J; Barnes TR; Chaudhry IB; Dazzan P; Husain N; Jones PB; Joyce EM; Lawrie SM; Upthegrove R; Deakin B
    Trials; 2015 Mar; 16():71. PubMed ID: 25886254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
    Calabrese JR; Keck PE; Macfadden W; Minkwitz M; Ketter TA; Weisler RH; Cutler AJ; McCoy R; Wilson E; Mullen J
    Am J Psychiatry; 2005 Jul; 162(7):1351-60. PubMed ID: 15994719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the potential anti-neuroinflammatory effect of minocycline in chronic low back pain: Protocol for a randomized, double-blind, placebo-controlled trial.
    Morrissey EJ; Alshelh Z; Knight PC; Saha A; Kim M; Torrado-Carvajal A; Zhang Y; Edwards RR; Pike C; Locascio JJ; Napadow V; Loggia ML
    Contemp Clin Trials; 2023 Mar; 126():107087. PubMed ID: 36657520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lurasidone in the treatment of bipolar depression with mixed (subsyndromal hypomanic) features: post hoc analysis of a randomized placebo-controlled trial.
    McIntyre RS; Cucchiaro J; Pikalov A; Kroger H; Loebel A
    J Clin Psychiatry; 2015 Apr; 76(4):398-405. PubMed ID: 25844756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspirin versus placebo for the treatment of venous leg ulcers-a phase II, pilot, randomised trial (AVURT).
    Helen T; Liz C; Laura C; Illary S; Martin B; Hannah B; Ian C; Jo D; Chris F; Rachael F; Rhian G; Keith H; Alison L; Ellie L; Catriona MD; Christine M; Debbie R; Gerard S; David T; Peter V; Laurie W; Robert H
    Trials; 2019 Jul; 20(1):459. PubMed ID: 31349862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.
    Quiroz JA; Tamburri P; Deptula D; Banken L; Beyer U; Rabbia M; Parkar N; Fontoura P; Santarelli L
    JAMA Psychiatry; 2016 Jul; 73(7):675-84. PubMed ID: 27304433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression: A Randomized Clinical Trial.
    McIntyre RS; Subramaniapillai M; Lee Y; Pan Z; Carmona NE; Shekotikhina M; Rosenblat JD; Brietzke E; Soczynska JK; Cosgrove VE; Miller S; Fischer EG; Kramer NE; Dunlap K; Suppes T; Mansur RB
    JAMA Psychiatry; 2019 Aug; 76(8):783-790. PubMed ID: 31066887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial.
    Ishikawa H; Mutoh M; Sato Y; Doyama H; Tajika M; Tanaka S; Horimatsu T; Takeuchi Y; Kashida H; Tashiro J; Ezoe Y; Nakajima T; Ikematsu H; Hori S; Suzuki S; Otani T; Takayama T; Ohda Y; Mure K; Wakabayashi K; Sakai T
    Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):474-481. PubMed ID: 33812492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin.
    Berk M; Mohebbi M; Dean OM; Cotton SM; Chanen AM; Dodd S; Ratheesh A; Amminger GP; Phelan M; Weller A; Mackinnon A; Giorlando F; Baird S; Incerti L; Brodie RE; Ferguson NO; Rice S; Schäfer MR; Mullen E; Hetrick S; Kerr M; Harrigan SM; Quinn AL; Mazza C; McGorry P; Davey CG
    BMC Med; 2020 Jan; 18(1):16. PubMed ID: 31948461
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.